Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer
Harsimar Kaur(Brigham and Women's Hospital), Tamara L. Lotan(Johns Hopkins University)
Cited by 100
Related Papers
PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients
|Clinical Cancer Research|2011|350
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.
|PubMed|2022|172
Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH
|Modern Pathology|2016|90
AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination
|Nature Communications|2017|50
mTORC1 loss impairs epidermal adhesion via TGF-β/Rho kinase activation
|Journal of Clinical Investigation|2017|40